|
1
|
Lozano R, Naghavi M, Foreman K, Lim S,
Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et
al: Global and regional mortality from 235 causes of death for 20
age groups in 1990 and 2010: A systematic analysis for the global
burden of disease study 2010. Lancet. 380:2095–2128. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang Y, Nagano H, Ota H, Morimoto O,
Nakamura M, Wada H, Noda T, Damdinsuren B, Marubashi S, Miyamoto A,
et al: Patterns and clinicopathologic features of extrahepatic
recurrence of hepatocellular carcinoma after curative resection.
Surgery. 141:196–202. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sbrissa D, Ikonomov OC and Shisheva A:
PIKfyve, a mammalian ortholog of yeast Fab1p lipid kinase,
synthesizes 5-phosphoinositides. Effect of insulin. J Biol Chem.
274:21589–21597. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shisheva A: PIKfyve: The road to PtdIns
5-P and PtdIns 3,5-P2. Cell Biol Int. 25:1201–1206.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takasuga S and Sasaki T:
Phosphatidylinositol-3,5-bisphosphate: Metabolism and physiological
functions. J Biochem. 154:211–218. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McCartney AJ, Zolov SN, Kauffman EJ, Zhang
Y, Strunk BS, Weisman LS and Sutton MA: Activity-dependent
PI(3,5)P2 synthesis controls AMPA receptor trafficking
during synaptic depression. Proc Natl Acad Sci USA.
111:E4896–E4905. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim J, Jahng WJ, Di Vizio D, Lee JS,
Jhaveri R, Rubin MA, Shisheva A and Freeman MR: The
phosphoinositide kinase PIKfyve mediates epidermal growth factor
receptor trafficking to the nucleus. Cancer Res. 67:9229–9237.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Oppelt A, Haugsten EM, Zech T, Danielsen
HE, Sveen A, Lobert VH, Skotheim RI and Wesche J: PIKfyve, MTMR3
and their product PtdIns5P regulate cancer cell migration and
invasion through activation of Rac1. Biochem J. 461:383–390. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ikonomov OC, Filios C, Sbrissa D, Chen X
and Shisheva A: The PIKfyve-ArPIKfyve-Sac3 triad in human breast
cancer: Functional link between elevated Sac3 phosphatase and
enhanced proliferation of triple negative cell lines. Biochem
Biophys Res Commun. 440:342–347. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oppelt A, Lobert VH, Haglund K, Mackey AM,
Rameh LE, Liestol K, Schink KO, Pedersen NM, Wenzel EM, Haugsten
EM, et al: Production of phosphatidylinositol 5-phosphate via
PIKfyve and MTMR3 regulates cell migration. EMBO Rep. 14:57–64.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dupuis-Coronas S, Lagarrigue F, Ramel D,
Chicanne G, Saland E, Gaits-Iacovoni F, Payrastre B and Tronchere
H: The nucleophosmin-anaplastic lymphoma kinase oncogene interacts,
activates, and uses the kinase PIKfyve to increase invasiveness. J
Biol Chem. 286:32105–32114. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sano O, Kazetani K, Funata M, Fukuda Y,
Matsui J and Iwata H: Vacuolin-1 inhibits autophagy by impairing
lysosomal maturation via PIKfyve inhibition. FEBS Lett.
590:1576–1585. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hessvik NP, Overbye A, Brech A, Torgersen
ML, Jakobsen IS, Sandvig K and Llorente A: PIKfyve inhibition
increases exosome release and induces secretory autophagy. Cell Mol
Life Sci. 73:4717–4737. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Galluzzi L, Baehrecke EH, Ballabio A, Boya
P, Bravo-San Pedro JM, Cecconi F, Choi AM, Chu CT, Codogno P,
Colombo MI, et al: Molecular definitions of autophagy and related
processes. EMBO J. 36:1811–1836. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee YK and Lee JA: Role of the mammalian
ATG8/LC3 family in autophagy: Differential and compensatory roles
in the spatiotemporal regulation of autophagy. BMB Rep. 49:424–430.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bhat P, Kriel J, Shubha Priya B, Basappa,
Shivananju NS and Loos B: Modulating autophagy in cancer therapy:
Advancements and challenges for cancer cell death sensitization.
Biochem Pharmacol. 147:170–182. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Heckmann BL, Yang X, Zhang X and Liu J:
The autophagic inhibitor3-methyladenine potently stimulates
PKA-dependent lipolysis in adipocytes. Br J Pharmacol. 168:163–171.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Er EE, Mendoza MC, Mackey AM, Rameh LE and
Blenis J: AKT facilitates EGFR trafficking and degradation by
phosphorylating and activating PIKfyve. Sci Signal. 6:ra452013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tan X, Thapa N, Sun Y and Anderson RA: A
kinase-independent role for EGF receptor in autophagy initiation.
Cell. 160:145–160. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hirano T, Munnik T and Sato MH: Inhibition
of phosphatidylinositol 3,5-bisphosphate production has pleiotropic
effects on various membrane trafficking routes in Arabidopsis.
Plant cell Physiol. 58:120–129. 2017.PubMed/NCBI
|
|
21
|
Ikonomov OC, Fligger J, Sbrissa D,
Dondapati R, Mlak K, Deeb R and Shisheva A: Kinesin adapter JLP
links PIKfyve to microtubule-based endosome-to-trans-Golgi network
traffic of furin. J Biol Chem. 284:3750–3761. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jin N, Jin Y and Weisman LS: Early
protection to stress mediated by CDK-dependent PI3,5P2
signaling from the vacuole/lysosome. J Cell Biol. 216:2075–2090.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bissig C, Hurbain I, Raposo G and van Niel
G: PIKfyve activity regulates reformation of terminal storage
lysosomes from endolysosomes. Traffic. 18:747–757. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dayam RM, Sun CX, Choy CH, Mancuso G,
Glogauer M and Botelho RJ: The lipid kinase PIKfyve coordinates the
neutrophil immune response through the activation of the Rac
GTPase. J Immunol. 199:2096–2105. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Du Z and Lovly CM: Mechanisms of receptor
tyrosine kinase activation in cancer. Mol Cancer. 17:582018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ye QH, Zhu WW, Zhang JB, Qin Y, Lu M, Lin
GL, Guo L, Zhang B, Lin ZH, Roessler S, et al: GOLM1 modulates
EGFR/RTK cell-surface recycling to drive hepatocellular carcinoma
metastasis. Cancer Cell. 30:444–458. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sainsbury JR, Farndon JR, Needham GK,
Malcolm AJ and Harris AL: Epidermal-growth-factor receptor status
as predictor of early recurrence of and death from breast cancer.
Lancet. 1:1398–1402. 1987.PubMed/NCBI
|
|
28
|
Li X and Fan Z: The epidermal growth
factor receptor antibody cetuximab induces autophagy in cancer
cells by downregulating HIF-1alpha and Bcl-2 and activating the
beclin 1/hVps34 complex. Cancer Res. 70:5942–5952. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li H, You L, Xie J, Pan H and Han W: The
roles of subcellularly located EGFR in autophagy. Cell Signal.
35:223–230. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen Y, Henson ES, Xiao W, Huang D,
McMillan-Ward EM, Israels SJ and Gibson SB: Tyrosine kinase
receptor EGFR regulates the switch in cancer cells between cell
survival and cell death induced by autophagy in hypoxia. Autophagy.
12:1029–1046. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jacob JA, Salmani JMM, Jiang Z, Feng L,
Song J, Jia X and Chen B: Autophagy: An overview and its roles in
cancer and obesity. Clin Chim Acta. 468:85–89. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sato H, Yamamoto H, Sakaguchi M, Shien K,
Tomida S, Shien T, Ikeda H, Hatono M, Torigoe H, Namba K, et al:
Combined inhibition of MEK and PI3K pathways overcomes acquired
resistance to EGFR-TKIs in non-small cell lung cancer. Cancer Sci.
109:3183–3196. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lanaya H, Natarajan A, Komposch K, Li L,
Amberg N, Chen L, Wculek SK, Hammer M, Zenz R, Peck-Radosavljevic
M, et al: EGFR has a tumour-promoting role in liver macrophages
during hepatocellular carcinoma formation. Nature Cell Biol.
16:972–977. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang Y, Wang L, Zhang M, Jin M, Bai C and
Wang X: Potential mechanism of interleukin-8 production from lung
cancer cells: An involvement of EGF-EGFR-PI3K-Akt-Erk pathway. J
Cell Physiol. 227:35–43. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang L, Li Y, Lan L, Liu R, Wu Y, Qu Q
and Wen K: Tamoxifen has a proliferative effect in endometrial
carcinoma mediated via the GPER/EGFR/ERK/cyclin D1 pathway: A
retrospective study and an in vitro study. Mol Cell Endocrinol.
437:51–61. 2016. View Article : Google Scholar : PubMed/NCBI
|
